✦ LIBER ✦

The use of high dose immunoablative therapy with hematopoietic stem cell support therapy in the treatment of severe autoimmune diseases

✍ Scribed by Alan Tyndall; Alois Gratwohl

Publisher: Carden Jennings Publishing
Year: 2002
Tongue: English
Weight: 573 KB
Volume: 76
Category: Article
ISSN: 0925-5710
DOI: 10.1007/bf03165249

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Salvage therapy with high-dose chemother

Salvage therapy with high-dose chemotherapy and autologous bone marrow support in the treatment of primary nonseminomatous mediastinal germ cell tumors

✍ E. R. Broun; C. R. Nichols; L. H. Einhorn; G. J. K. Tricot 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 268 KB 👁 2 views

Intensive multimodality therapy includin

Intensive multimodality therapy including paclitaxel and reduced-intensity allogeneic hematopoietic stem cell transplantation in the treatment of adrenal cancer with multiple metastases

✍ Osamu Imataki; Atsushi Makimoto; Rie Kojima; Michiyo Sakiyama; Ako Hosono; Yoich 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 252 KB

High dose chemotherapy with autologous s

High dose chemotherapy with autologous stem cell support in the treatment of patients with ovarian carcinoma : Long term results for 105 patients

✍ Takao Shinozuka; Tsuyoshi Miyamoto; Toshinari Muramatsu; Takeshi Hirasawa; Masar 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 132 KB 👁 2 views

## BACKGROUND. In this study, the authors reviewed long term results and prognostic factors of high dose chemotherapy (HDC) with autologous stem cell support administered to 105 patients with epithelial ovarian carcinoma. ## METHODS. Prior to HDC, platinum-based chemotherapy was given to optimi

High-dose alkylation therapy using ifosf

High-dose alkylation therapy using ifosfamide infusion with mesna in the treatment of adult advanced soft-tissue sarcoma

✍ Robin C. Stuart-Harris; Peter G. Harper; Colin A. Parsons; Stanley B. Kaye; Caro 📂 Article 📅 1983 🏛 Springer 🌐 English ⚖ 463 KB

In a phase II study, 42 patients with advanced soft-tissue sarcoma were treated with ifosfamide by 24-h infusion and mesna by 4-h IV bolus, repeated every 3 weeks. Ten patients received ifosfamide 5.0 g/m2, 20 had the dosage increased to 8.0 g/m2, and 12 received 8.0 g/m2 from the outset. Mesna was